Connect with us

Medical Research

Mutiple New Studies: Patients Start Preferring Marijuana Over Prescription Medication

Pouline Ireri

Published

on

Mutiple New Studies: Patients Start Preferring Marijuana Over Prescription Medication

Two studies examined if marijuana use reduced opioid use. While the first study used data from the National Survey on Drug Use, the other study surveyed patients that use opioids and medical marijuana.

The ability of cannabis to help eradicate pain has been one of the most publicized benefits of the substance, and it is clear that the public is interested. Though there has been previous evidence to suggest that patients are seeking out medical marijuana for their pain, two additional studies have recently come out to further support this concept. As Marijuana Moment states, the discoveries of these studies are some of the latest in the research towards dealing with the opioid crisis in the US.

The International Journal of Drug Policy published the first study, hoping to see if the substitution of marijuana for opioids for pain relief if “plausible.” Data from the National Survey on Drug Use was used by researchers at the Florida International University to see if the citizens who had legal access in their state to cannabis were more likely to use opioids or medical cannabis for their relief.

The researchers dealt with a few variables in their research, including:

  • If prescription painkillers were used or misused in the last year
  • The states that the respondents lived in
  • If the state had legalized cannabis for medicinal purposes

The survey reviewed the responses of 120,764 participants, based on information from 2015 to 2017. The authors stated, “The results generated from the multivariate logistic regression equations show that [medical marijuana laws] are associated with a lower likelihood of opioid pain reliever use, but not misuse.”

The results suggest that the use of medical marijuana could realistically reduce the necessity that patients feel for opioids, and that the individuals that lived in states with legal medical marijuana reported less opioid abuse. Clearly, the study concludes that they found that patients were more likely to prefer medical marijuana over opioids. Furthermore, the study stated:

“Such subjective appraisals by patients are important in this context as the success of a treatment plan is in part determined by the patient’s perceptions of treatment efficacy and tolerance of side effects.”

In the second study, PLoS ONE discussed if patients were using medical marijuana in place of prescription painkillers, taking their information directly from the people. The survey they used involved 16,280 adults, asking them to share details about their use of opioids and marijuana. The researchers also examined whether the amount of opioid medications necessary for pain was different with the us of marijuana, and why patients would choose to make this substitute.

Over half of the people who were asked to participate ultimately chose to respond, totaling 9,003 respondents. Approximately 5% stated that they’d used marijuana and opioids in the last 12 months, though 43% reported daily opioid use and 23% stated that they’d used marijuana in the last month. The study found that marijuana use was attached to the decrease or stopping of opioid use in 41% of respondents. No change in opioid use was reported by 46% of respondents, and a small 8% of respondents increased the amount of opioids used with marijuana use.

The authors of the study stated, “The most commonly reported reasons for substitution were better pain management (36%) and fewer side effects (32%) and withdrawal symptoms (26%), compared to the non-medical reasons for use: cheaper (13%) and more social acceptance from marijuana use (13%).”

The researchers from the second study comment that additional research is necessary to draw any concrete conclusions but admits that the findings imply that patients believe they use less opioids with medical marijuana use. Both studies point to the need for patient-centered care to manage the use and potential misuse of opioids.

Pouline Ireri lives in Kenya and is new at TOC but plans to contribute much more in the near future. She graduated from the University of Nairobi and is a Business consultant/Micro Finance specialist. Her affinity for cannabis and CBD came naturally through her own use and become an advocate based on the positive effects and results she experienced.

Continue Reading
Ultimate CBD Guide

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

CBD News Updates

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational purposes only.

Got news? Email contact@timesofcbd.com